Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2013 Oct 18;2013(10):CD004471.
doi: 10.1002/14651858.CD004471.pub3.

Corticosteroids for viral myocarditis

Huai Sheng Chen  1 , Wei Wang, Sheng Nan Wu, Jian Ping Liu
Affiliations
Meta-Analysis

Corticosteroids for viral myocarditis

Huai Sheng Chen et al. Cochrane Database Syst Rev. .

Abstract

Background: Myocarditis is defined as inflammation of the myocardium accompanied by myocellular necrosis. Experimental evidence suggests that autoimmune mechanisms follow viral infection, resulting in inflammation and necrosis in the myocardium. However, the use of corticosteroids as immunosuppressives for this condition remains controversial.

Objectives: The existing review was updated. The primary objective of this review is to assess the beneficial and harmful effects of treating acute or chronic viral myocarditis with corticosteroids. The secondary objective is to determine the best dose regimen.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL, Issue 7 of 12, 2012) on The Cochrane Library, MEDLINE OVID (1946 to July Week 2, 2012), EMBASE OVID (1980 to Week 29, 2012), BIOSIS Previews (1969 to 20 July 2012), ISI Web of Science (1970 to 20th July, 2012), and LILACS (from its inception to 25 July, 2012) , Chinese Biomed Database, CNKI and WANFANG Databases (from their inception to 31 December 2012). We applied no language restrictions.

Selection criteria: Randomised controlled trials (RCTs) of corticosteroids for viral myocarditis compared with no intervention, placebo, supportive therapy, antiviral agents therapy or conventional therapy, including trials of corticosteroids plus other treatment versus other treatment alone, irrespective of blinding, publication status, or language.

Data collection and analysis: Two review authors extracted data independently. Results were presented as risk ratios (RRs) and mean differences (MDs), both with 95% confidence intervals (CIs).

Main results: Eight RCTs (with 719 participants) were included in this update. The trials were small in size and methodological quality was poor. Viral detection was performed in 38% of participants, among whom 56% had positive results. Mortality between corticosteroids and control groups was non-significant (RR, 0.93, 95% CI 0.70 to 1.24). At 1 to 3 months follow-up, left ventricular ejection fraction (LVEF) was higher in the corticosteroids group compared to the control group (MD 7.36%, 95% CI 4.94 to 9.79), but there was substantial heterogeneity. Benefits were observed in LVEF in two trials with 200 children given corticosteroids (MD 9.00%, 95% CI 7.48 to 10.52). New York Heart Association (NYHA) class and left ventricular end-stage systole diameter (LVESD) were not affected. Creatine phosphokinase (CPK) (MD -104.00 U/L, 95% CI -115.18 to -92.82), Isoenzyme of creatine phosphate MB (CKMB) (MD 10.35 U/L, 95% CI 8.92 to 11.78), were reduced in the corticosteroids group compared to the control group, although the evidence is limited to small participant numbers. There were insufficient data on adverse events.

Authors' conclusions: For people diagnosed with viral myocarditis and low LVEF, corticosteroids do not reduce mortality. They may improve cardiac function but the trials were of low quality and small size so this finding must be regarded as uncertain. High-quality, large-scale RCTs should be careful designed to determine the role of corticosteroid treatment for viral myocarditis. Adverse events should also be carefully evaluated.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Flow diagram
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1: Mortality, Outcome 1: Mortality
1.2
1.2. Analysis
Comparison 1: Mortality, Outcome 2: Clinical endpoint (death and heart transplantation rates)
1.3
1.3. Analysis
Comparison 1: Mortality, Outcome 3: Mortality in children
2.1
2.1. Analysis
Comparison 2: Myocardial function, Outcome 1: NYHA class at follow‐up
2.2
2.2. Analysis
Comparison 2: Myocardial function, Outcome 2: LVEF at 1 ‐ 3 months follow‐up
2.3
2.3. Analysis
Comparison 2: Myocardial function, Outcome 3: LVEF at 1 ‐ 3 months in children
2.4
2.4. Analysis
Comparison 2: Myocardial function, Outcome 4: LVEF at long‐term follow‐up
2.5
2.5. Analysis
Comparison 2: Myocardial function, Outcome 5: LVEDD at the end of observation
2.6
2.6. Analysis
Comparison 2: Myocardial function, Outcome 6: LVESD at one‐year follow‐up
3.1
3.1. Analysis
Comparison 3: Myocardial enzyme, Outcome 1: Level of Creatine Phosphokinase
3.2
3.2. Analysis
Comparison 3: Myocardial enzyme, Outcome 2: Level of Creatine Phosphokinase‐MB
3.3
3.3. Analysis
Comparison 3: Myocardial enzyme, Outcome 3: alpha‐HBDH
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Aziz 2010 {published data only}
    1. Aziz KU, Patel N, Sadullah T, Tasneem H, Thawerani H, Talpur S. Acute viral myocarditis: role of immunosuppression: a prospective randomised study. Cardiology in the Young 2010;20(5):509-15. - PubMed
Latham 1989 {published data only}
    1. Latham RD, Mulrow JP, Virmani R, Robinowitz M, Moody JM. Recently diagnosed idiopathic dilated cardiomyopathy: incidence of myocarditis and efficacy of prednisone therapy. American Heart Journal 1989;117(4):876-882. - PubMed
Liao 2005 {published data only}
    1. Liao RH, Li L, Wang X. Therapeutic effects of comprehensive program plus hormone on viral myocarditis. Acta Academiae Medicinae Militaris Tertiae (Chinese) 2005;27(6):575-6.
Ma 2001 {published data only}
    1. Ma PaiRan, Wang ShuJun, Zhuang JianXin, Huang Lei. The treatment effect of corticosteroids on reducing myocardial enzyme in viral myocarditis in children. Shan Dong Medical Journal 2001;41(19):13-14.
Maisch 1995 {published data only}
    1. Maisch B, Herzum M, Hufnagel G, Hengstenberg C, Schonian U, Bittinger A, et al. Immunosuppressive treatment in auto-reactive myocarditis: results from a placebo-controlled trial. Journal of the American College of Cardiology 1995;Special Issue:325A.
    1. Maisch B, Herzum M, Hufnagel G, Hengstenberg C, Schonian U, Bittinger A, et al. Immunosuppressive treatment in auto-reactive myocarditis results from a placebo-controlled trial. Journal of the American College of Cardiology 1993;21(2 Suppl A):21A.
    1. Maisch B, Schonian U, Hengstenberg C, Herzum M, Hufnagel G, Bethge C, et al. Immunosuppressive treatment in autoreactive myocarditis--results from a controlled trial. Postgraduate Medical Journal 1994;70(Suppl 1):S29-34. - PubMed
Mason 1995 {published data only}
    1. Hahn EA, Hartz VL, Moon TE, O'Connell JB, Herskowitz A, Mcmanus BM, et al. The myocarditis treatment trial: design, methods and patient enrolment. European Heart Journal 1995;16(Suppl):162-7. - PubMed
    1. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis: The Myocarditis Treatment Trial Investigators. New England Jounral of Medicine 1995;333(5):269-75. - PubMed
Wojnicz 1999 {published data only}
    1. Wojnicz R, Nowalany-Kozielska E, Szczurek-Katanski K, Wodniecki J, Nozynski J, Zembala M, et al. Randomized studies of new therapeutic management in patients with myocarditis. Journal of the American College of Cardiology 1999;2(Suppl A):506A.
    1. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001;104(1):39-45. [PMID: ] - PubMed
Yang 2006 {published data only}
    1. Yang CQ, Ding DP. Treatment effects of Shenmai injection combined corticosteroids on acute viral myocarditis in children. Lishizhen Medicine and Materia Medica Research 2006;17(5):872-3.

References to studies excluded from this review

Camargo 1995 {published data only}
    1. Camargo PR, Snitcowsky R, Da Luz PL, Mazzieri R, Higuchi ML, Rati M, et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatric Cardiology 1995;16(2):61-8. - PubMed
Chen 1992 {published data only}
    1. Chen SX, Chang BL, Bao SH. Integrated traditional and Western medicine treatment of severe viral myocarditis. Zhongguo Zhong Xi Yi Jie He Za Zhi 1992;12(7):398-401. - PubMed
ESETCID 2000 {published data only}
    1. Hufnagel G, Pankuweit S, Richter A, Schonian U, Maisch B. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz 2000;25(3):279-285. - PubMed
    1. Maisch B, Hufnagel G, Schonian U, Hengstenberg C. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). European Heart Journal 1995;16(Suppl O):173-5. - PubMed
Frustaci 2009 {published data only}
    1. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. European Heart Journal 2009;30(16):1995-2002. - PubMed
Kong 2001 {published data only}
    1. Kong Qing-fu, Song Shu-zhi, Xie Xue-ying, Zhang Xin-hua, Yue Ge-jie, Chen Zhao-li. Clinical study on therapeutic effects of treatment according to syndrome differentiation of Traditional Chinese Medicine combined with captopril on severe viral myocarditis complicated heart failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001;21(7):513-5. - PubMed
Li 1997 {published data only}
    1. Li SenLin, Zhang ZhiGan, Zhou PengYu. Effect of synthetic action of HuangQi, cortisone on acute viral myocarditis. ZhongGuo Zhong Xi Yi Jie He Za Zhi 1997;17(2):118-9.
Ma 2002 {published data only}
    1. Ma PaiRan, Wang ShuJun, Yang XiaoHui, Ouyan ShiXiang. The differentia and value of anticardiolipin antibody between pre- and pro- treatment of corticosteroids in children with viral myocarditis. Shandong Medical Journal 2002;42(23):1-3.
Mao 2007 {published data only}
    1. Mao KeJiang, Li YiNan. Application research on staged immunological intervention in viral myocarditis patients. Modern Hospital 2007;7(6):31-3.
Sun 1999 {published data only}
    1. Sun Dabao. Corticosteroids treatment effects in 36 cases diagnosed with viral myocarditis with ventricle premature beats. Journal of Zhenjiang Medical College 1999;9(2):211.
Wu 1999 {published data only}
    1. Wu Yao-zhang, Chen Bing-Wang. Observation on curative effects of astragalus injection combined with glucocorticoid on acutely severe viral myocarditis. Zhongguo Zhong Xi Yi Jie He Ji Jiu Za Zhi 1999;6(8):350-2.
Zhang 2006 {published data only}
    1. Zhang ChunTang, Li AnMin, Li Na. Effect of calcium dibutyryladenosine cyclophosph-ate on viral myocarditis. Central Plains Medical Journal 2006;33(8):80-81.
Zhang 2008 {published data only}
    1. Zhang JinFu. Effects of 1,6-FDP combined HuangQi injection on 30 children with viral myocardiits. China Eugenic Genetics Medicine 2008;16(6):131-2.

Additional references

Adedayo 2011
    1. Adedayo O, Iheonunekwu N, Jefferson D. Acute fulminant myocarditis and the 2009 pandemic influenza A virus (H1N1). West Indian Medical Journal 2011;60(2):217-9. - PubMed
Andreoletti 2009
    1. Andreoletti L, Leveque N, Boulagnon C, Brasselet C, Fornes P. Viral causes of human myocarditis. Archives of Cardiovascular Disease 2009;102(6-7):559-68. - PubMed
Angelini 2000
    1. Angelini A, Calzolari V, Calabrese F, Boffa GM, Maddalena F, Chioin R, et al. Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart 2000;84(3):245-50. - PMC - PubMed
Barbaro 2011
    1. Barbaro G, Barbarini G. Human immunodeficiency virus and cardiovascular risk. Indian Journal of Medical Research 2011;134(6):898-903. - PMC - PubMed
Batra 2001
    1. Batra AS, Lewis AB. Acute myocarditis. Currence Opinion in Pediatrics 2001;13(3):234-9. - PubMed
Baughman 2006
    1. Baughman KL. Diagnosis of myocarditis-death of Dallas Criteria. Circulation 2006;113(4):593-5. - PubMed
Cabral 2012
    1. Cabral M, Brito MJ, Conde M, Oliveira M, Ferreira G. Fulminant myocarditis associated with pandemic H1N1 influenza A virus. Revista Portuguesa de Cardiologia [Portuguese Journal of Cardiology] 2012;31(7-8):517-20. - PubMed
Calderaro 2010
    1. Calderaro D, Dos Santos Sde S, Tonacio AC, Gualandro DM, Rezende PC, Yu PC, et al. Acute myocarditis in H1N1 influenza A virus infection. Revista Associação da Médica Brasiliera 2010;56(4):394. - PubMed
Chan 1991
    1. Chan KY, Iwahara M, Benson LN, Wilson GJ, Freedom RM. Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial. Journal of the American College of Cardiology 1991;17(2):458-60. - PubMed
Chen 2008
    1. Chen HS, Wen JM, Wu SN. Clinical management and relevant issues of viral myocarditis. Chinese Journal of Practical Internal Medicine 2008;28(6):510-2.
Cheng 2003
    1. Cheng TO. Prevalence of viral myocarditis. Archives of Internal Medicine 2003;163(14):1742. [PMID: ] - PubMed
Egger 1997
    1. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. - PMC - PubMed
Fukae 2000
    1. Fukae S, Ashizawa N, Morikawa S, Yano K. A fatal case of fulminant myocarditis with human herpes virus-6 infection. Internal Medicine 2000;39(8):632-6. - PubMed
Gagliardi 2004
    1. Gagliardi MG, Bevilacqua M, Bassano C, Leonardi B, Boldrini R, Camassei FD. Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart 2004;90(10):1167-71. - PMC - PubMed
Garg 1998
    1. Garg A, Shiau J, Guyatt G. The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis: an overview. Ann Intern Med 1998;129(4):317-22. - PubMed
Gdynia 2011
    1. Gdynia G, Schnitzler P, Brunner E, Kandolf R, Blaker H, Daum E, et al. Sudden death of an immunocompetent young adult caused by novel (swine origin) influenza A/H1N1-associated myocarditis. Virchows Archiv 2011;458(3):371-6. - PubMed
Haessler 2011
    1. Haessler S, Paez A, Rothberg M, Higgins T. 2009 pandemic H1N1-associated myocarditis in a previously healthy adult. Clinical Microbiology and Infection 2011;17(4):572-4. - PubMed
Hamilton 2009
    1. Hamilton TW, Goodman SM, Figgie M. SAS weekly rounds: avascular necrosis. HSS Journal 2009;5(2):99-113. - PMC - PubMed
Heininger 2011
    1. Heininger A, Haeberle HA, Fischer I, Beck R, Riessen R, Rohde F, et al. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Critical Care 2011;15(2):R77. - PMC - PubMed
Hia 2004
    1. Hia CP, Yip WC, Tai BC, Quek SC. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Archives of Disease in Childhood 2004;89(6):580-4. [PMID: ] - PMC - PubMed
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Hosenpud 1985
    1. Hosenpud JD, McAnulty JH, Niles NR. Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azathioprine and prednisone. Journal of the American College of Cardiology 1985;6(4):797-801. - PubMed
ICH‐GCP 1997
    1. International Conference on Harmonisation Expert Working Group. Code of Federal Regulations & International Conference on Harmonisation Guidelines. Philadelphia: Barnett International/PAREXEL, 1997.
Kalil 2011
    1. Kalil AC, Florescu DF. Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis? Critical Care 2011;15(2):138. - PMC - PubMed
Kandolf 2011
    1. Kandolf R. Diagnosis of myocarditis. Deutsche Medizinische Wochenschrift 2011;136(16):829-35. - PubMed
Kearney 2001
    1. Kearney MT, Cotton JM, Richardson PJ, Shah AM. Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management. Postgraduate Medical Journal 2001;77(903):4-10. - PMC - PubMed
Kraaij 2011
    1. Kraaij MD, Van der Kooij SW, Reinders ME, Koekkoek K, Rabelink TJ, Van Kooten C, et al. Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages. Molecular Immunology 2011;49(3):549-57. - PubMed
Liu 1996
    1. Liu P, Martimo T, Opavsky MA, Penninger J. Viral myocarditis: balance between viral infection and immune response. Canadian Journal of Cardiology 1996;12(10):935-43. - PubMed
Liu 2013
    1. Liu ZL, Liu ZJ, Liu JP, Kwong JSW. Herbal medicines for viral myocarditis. Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No: CD003711. [DOI: 10.1002/14651858.CD003711.pub5] - DOI - PubMed
Ma 1999
    1. Ma WZ, Yu JD, Liu ZQ, Wu N, Li LG, Chen HZ, et al Committee of Myocarditis and Cardiomyopathy: Dealing meeting of Chinese Journal of Cardiovascular Disease. Viewpoints of diagnostic criteria of adult acute viral myocarditis and introduction to the definition and classification of cardiomyopathy of WHO/IHA workshop. Chinese Journal of Cardiovascular Disease 1999;27(6):405-7.
Magula 2003
    1. Magula NP, Mayosi BM. Cardiac involvement in HIV-infected people living in Africa: a review. Cardiovascular Journal of South Africa 2003;14(5):231-7. [PMID: ] - PubMed
Mahrholdt 2004
    1. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109(10):1250-8. - PubMed
Mason 2003
    1. Mason JW. Myocarditis and dilated cardiomyopathy: An inflammatory link. Cardiovascular Research 2003;60(1):5-10. - PubMed
McKenna 1996
    1. McKenna WJ. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93(5):841-2. - PubMed
McNamara 2002
    1. McNamara DM. Diagnosis and medical treatment of inflammatory cardiomyopathy. In: Eric J Topol, editors(s). Textbook of Cardiovascular Medicine. 2nd edition. Shangdong, China: Lippincott Williams & Wilkins; Shangdong Science & Technology Press, 2002:1899-1913. [7-5331-3409-5]
Metzger 2011
    1. Metzger TC, Anderson MS. Myocarditis: a defect in central immune tolerance? Journal of Clinical Investigation 2011;121(4):1251-3. - PMC - PubMed
Opitz 2011
    1. Opitz E, Koch A, Klingel K, Schmidt F, Prokop S, Rahnefeld A, et al. Impairment of immunoproteasome function by β5i/LMP7 subunit deficiency results in severe enterovirus myocarditis. PLoS Pathogens 2011;7(9):e1002233. - PMC - PubMed
Orinius 1968
    1. Orinius E. The late cardiac prognosis after Coxsackie-B infection. Acta Medica Scandinavica 1968;183:235-7. - PubMed
Pietra 2012
    1. Pietra BA, Kantor PF, Bartlett HL, Chin C, Canter CE, Larsen RL, et al. Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy. Circulation 2012;126(9):1079-86. - PMC - PubMed
Salluh 2010
    1. Figueira Salluh JI, Bozza FA, Japiassu AM, Castro Faria Neto HC, Bozza PT, Póvoa P. Corticosteroids in sepsis: pathophysiological rationale and selection of patients. Endocrine, Metabolic & Immune Disorders Drug Targets 2010;10(3):266-73. - PubMed
Salvi 1989
    1. Salvi A, Di LA, Dreas L, Silvestri F, Camerini F. Immunosuppressive treatment in myocarditis. International Journal of Cardiology 1989;22(3):329-38. - PubMed
Schultz 2009
    1. Schultz JC, Hilliard AA, Cooper LT, Rihal CS. Diagnosis and treatment of viral myocarditis. Mayo Clinic Proceedings 2009;84(11):1001-9. - PMC - PubMed
Shauer 2013
    1. Shauer A, Gotsman I, Keren A, Zwas DR, Hellman Y, Durst R, et al. Acute viral myocarditis: current concepts in diagnosis and treatment. Israel Medical Association Journal 2013;15(3):180-5. - PubMed
Simon 2008
    1. Simon F, Paule P, Oliver M. Case Report: chikungunya virus-induced myopericarditis: toward an increase of dilated cardiomyopathy in countries with epidemics? American Journal of Tropical Medicine and Hygiene 2008;78(2):212-3. - PubMed
Sprung 2011
    1. Sprung CL, Goodman S, Weiss YG. Steroid therapy of septic shock. Critical Care Nursing Clinics of North America 2011;23(1):171-80. - PubMed
Tong 2011
    1. Tong P, Wu C, Jin H, Mao Q, Yu N, Holz JD, et al. Gene expression profile of steroid-induced necrosis of femoral head of rats. Calcified Tissue International 2011;89(4):271-84. - PubMed
Uemura 2001
    1. Uemura A, Morimoto S, Hiramitsu S, Hishida H. Endomyocardial biopsy findings in 50 patients with idiopathic atrioventricular block: presence of myocarditis. Japanese Heart Journal 2001;42(6):691-700. - PubMed
Ukimura 2012
    1. Ukimura A, Ooi Y, Kanzaki Y, Inomata T, Izumi T. A national survey on myocarditis associated with influenza H1N1pdm2009 in the pandemic and post-pandemic season in Japan. Journal of Infection and Chemotherapy 2012;19(3):426-31. - PubMed
Vester 1997
    1. Vester EG, Klein RM, Kuhl U, Schultheiss HP, Perings C, Hennersdorf M. Immunosuppressive therapy for effective suppression of life threatening ventricular tachyarrhythmias in chronic myocarditis. Zeitschrift fur Kardiologie 1997;86(4):298-308. - PubMed
Yang 2011
    1. Yang F, Wu WF, Yan YL, Pang Y, Kong Q, Huang YL. Expression of IL-23/Th17 pathway in a murine model of Coxsackie virus B3-induced viral myocarditis. Virology Journal 2011;8:301. - PMC - PubMed
Zahariadis 2003
    1. Zahariadis G, Jerome KR, Corey L. Herpes simplex virus-associated sepsis in a previously infected immunocompetent adult. Annals of Internal Medicine 2003;139(2):153-4. - PubMed
Zimmermann 2005
    1. Zimmermann O, Kochs M, Zwaka TP, Kaya Z, Lepper PM, Bienek-Ziolkowski M, et al. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. International Journal of Cardiology 2005;104(1):92-100. - PubMed

References to other published versions of this review

Chen 2006
    1. Chen HS, Yang M, Liu J. Corticosteroids for viral myocarditis. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No: CD004471. [DOI: 10.1002/14651858.CD004471.pub2] - DOI - PubMed

Publication types